Management of Transient Ischemic Attacks

Indications for Hospital Admission

Patients with a first TIA within the past 24-48 hours, crescendo TIAs, symptom duration >1 hour, symptomatic internal carotid stenosis >50%, known cardiac source of embolism, or known hypercoagulable state should be considered for hospital admission, as recommended by the American Academy of Neurology 1

Aspirin is indicated for patients with TIA to prevent recurrent ischemic events, with a recommended dose of 75-325 mg daily, as stated by the American College of Physicians and the American Academy of Family Physicians 2, 3, 4
Dual antiplatelet therapy (DAPT) with aspirin 81 mg daily plus clopidogrel 75 mg daily should be initiated as early as possible, ideally within 12-24 hours of symptom onset, after excluding intracranial hemorrhage on neuroimaging, and continued for 21 days, as recommended by the American Heart Association 4, 5
Long-term DAPT beyond the initial 21-30 day period should be avoided due to increased bleeding risk, unless patients have acute coronary syndromes or recent vascular stenting, as stated by the American Heart Association 4, 6

Warfarin is primarily indicated for cardioembolic TIAs, such as those associated with atrial fibrillation, as stated by the American College of Physicians, which publishes the Annals of Internal Medicine 2
Direct oral anticoagulants (DOACs) such as dabigatran, rivaroxaban, apixaban, or edoxaban are preferred over warfarin when possible, with a target INR of 2.5 (range 2.0-3.0) for vitamin K antagonists (VKAs), as recommended by the American Heart Association 7, 8

Target systolic blood pressure <140 mmHg for patients with TIA, including those with intracranial atherosclerotic stenosis, as recommended by the American Academy of Neurology and the American Heart Association 5, 1
Target blood pressure should be <140/90 mmHg or <130/80 mmHg for diabetics, with initiation of BP-lowering medication unless symptomatic hypotension is present, as recommended by the American Academy of Neurology, the American Heart Association, and the American College of Cardiology 1
ACE inhibitors, such as lisinopril, are recommended as first-line therapy for patients with hypertension and a history of stroke/TIA, as stated by the American College of Cardiology and the American Heart Association 9, 10

High-intensity statin therapy should be initiated regardless of baseline LDL levels, with a target LDL <100 mg/dL, to reduce the risk of recurrent stroke, as recommended by the American College of Cardiology and the American Heart Association 4, 11

Carotid endarterectomy is recommended for symptomatic patients with recent (within 2-4 weeks) TIA and ipsilateral 70-99% carotid stenosis, and should be considered for patients with 50-69% stenosis, as suggested by the American Academy of Neurology and the American College of Cardiology 1

Patients with TIA should be educated on stroke warning signs and symptoms, medication adherence, blood pressure monitoring and control, diabetes management, and the importance of a heart-healthy diet and regular physical activity, as recommended by the American Academy of Neurology and the American Heart Association 11, 1
Lifestyle modifications, including smoking cessation, weight reduction for BMI >25, regular physical activity, and reduced salt intake, are recommended for TIA patients, as suggested by the American Academy of Neurology, the American Heart Association, and the American College of Cardiology 1

Neuroimaging to exclude hemorrhage before initiating therapy, monitor for bleeding complications, and follow-up with neurology within 1-2 weeks after discharge, as recommended by the American Heart Association 5
Regular blood pressure and lipid monitoring, as well as follow-up with primary care physician within 1 week after discharge, are recommended, as stated by the American College of Cardiology and the American Heart Association 11, 1
Essential investigations for TIA patients include brain imaging (CT or MRI), vascular imaging (carotid Doppler ultrasound for anterior circulation symptoms), ECG, and blood tests (CBC, electrolytes, creatinine, glucose, lipids), as recommended by the American Academy of Neurology and the American College of Cardiology 1

Avoid omeprazole or esomeprazole with clopidogrel as they reduce its antiplatelet effectiveness, as stated by the American Heart Association 6
Avoid delaying antiplatelet therapy, using anticoagulants for non-cardioembolic TIAs, continuing DAPT beyond recommended duration, and overlooking medication interactions, as recommended by the American Heart Association 6